AI Science Tracker
EN

DNN stratifies kidney cancer survival using ten cuproptosis-related genes

Shanghai Jiao Tong University School of Medicine; University of Shanghai for Science and Technology · 22 Dec 2023 · medicine

Discovery

DNN stratifies kidney cancer survival using ten cuproptosis-related genes

Source check: Source checked. Not independent scientific confirmation.

Finding: A deep neural network trained on ten cuproptosis-related gene-expression features stratified kidney clear-cell cancer survival in TCGA and was evaluated in an external ICGC dataset. The authors report AUCs of 0.739 in training and 0.707 in validation. This was retrospective database analysis; proposed drug-target interactions remain computational predictions and clinical benefit was not tested.

Technology: Deep neural network

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A three-hidden-layer DNN trained on ten cuproptosis-related expression features in TCGA predicts KIRC survival with external ICGC evaluation.
Test and result
Retrospective TCGA survival modeling and external ICGC evaluation.
Limitation / still unknown
Prospective performance, clinical benefit and predicted drug-target mechanisms were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10807644/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary full paper Methods, Results and limitations plus Europe PMC bibliographic metadata;reviewed 2026-11-21..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.